1-20 of 301
smoldering myeloma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Crystal-storing histiocytosis associated with smoldering myeloma

Free
Sanne J. de Haart, Roos J. Leguit
Journal: Blood
Blood (2021) 138 (4): 354.
https://doi.org/10.1182/blood.2021010907
Published: 2021
Journal Articles

Localized Pulmonary Amyloidosis: A Single Institution Experience

Free
Ajay Tambe, MBBS, Poornima Ramadas, MBBS, Mijung Lee, MD, Kanish Mirchia, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5464.
https://doi.org/10.1182/blood-2019-125124
Published: 2019
Journal Articles

Profile of Long-Term Survivors in Multiple Myeloma

Free
Florence Sabirou, Gautier Defossez, MD, Pierre Ingrand, PhD, Isabelle Azais, MD, Geraldine Durand, MD, Niels Moya, Cécile Gruchet, Anthony Levy, Arthur Bobin, Helene Gardeney, Laly Nsiala, Carine Motard, MD, Gaelle Olivier, MD, Anne Corby, MD, Christophe Roul, MD, Thomas Systchenko, MD, Jocelyn Barrier, MD, Celine Dieval, MD, Florence Borde, MD, Olivier Fitoussi, MD, Antoine Machet, MD, Pierre Jamet, MD, Jeremie Diolez, MD, Stephanie Guidez, MD, Xavier Leleu, MD PhD, Mathieu Puyade, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5522.
https://doi.org/10.1182/blood-2019-127519
Published: 2019
Journal Articles

Protocol for an International, Multi-Centre, Retrospective Study to Describe Treatment Pathways, Outcomes and Resource Use in Patients with Multiple Myeloma (INTEGRATE)

Free
Su-Peng Yeh, MD, Fahad Alsharif, MD DIM, MB ChB, Meral Beksac, MD, Wenming Chen, PhD, Dorotea Fantl, MD, Tatiana Mitina, MD PhD, Estelle Verburgh, MBChB, M MDInt, FCPSA, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Kwang-Wei Wu, MD, Zijing Zhang, PhD, Hui Wan, MD PhD, Kihyun Kim, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5577.
https://doi.org/10.1182/blood-2019-122732
Published: 2019
Journal Articles

A Molecular Signature of Three tRNA-Derived RNA Fragments May Discriminate Smoldering from Symptomatic Multiple Myeloma Patients

Free
Paraskevi Karousi, BSc, Aristea-Maria Papanota, MD, Pinelopi I Artemaki, BSc, Christine Liacos, MSc, Christos K. Kontos, PhD, Dimitris Patseas, BSc, Aikaterini-Anna Liosi, BSc, Nefeli Mavrianou-Koutsoukou, BSc, Maria-Anna Kalioraki, BSc, Despina Fotiou, BMBS, MA, Ioannis Ntanasis-Stathopoulos, MD, Magdalini Migkou, MD, Panagiotis Malandrakis, MD, Maria Gavriatopoulou, MD, Eftathios Kastritis, Evangelos Terpos, MD PhD, Andreas Scorilas, PhD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5528.
https://doi.org/10.1182/blood-2019-129082
Published: 2019
Journal Articles

Update on Risk Stratification Model of Smoldering Multiple Myeloma: A Systematic Review

Free
Saad Ullah Malik, MD, Ahmad Abu-Hashyeh, MBBS, Muhammad Sardar, MD, Mohammad M Alhousani, Emilia Cindy Leigh, MD, Mohamed Suliman, MD, Abdul Mughees Rana, MD, Samson Teka, Eva Tackett, Faiz Anwer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5512.
https://doi.org/10.1182/blood-2019-132260
Published: 2019
Journal Articles

Real Life Use of Imaging in the Management of Newly Diagnosed Patients with Myeloma- Practical Perspectives from a UK Hospital

Free
Ke Xu, MD, Lucy Fowkes, Fenella Willis, Yasmin Reyal
Journal: Blood
Blood (2019) 134 (Supplement_1): 5513.
https://doi.org/10.1182/blood-2019-121504
Published: 2019
Journal Articles

Coexistence of B-Cell Dyscrasia with Large Granular Lymphocytic Leukemia

Free
Hassan Awada, Jibran Durrani, Ashwin Kishtagari, MBBS, Valeria Visconte, PhD, Reda Z. Mahfouz, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3750.
https://doi.org/10.1182/blood-2019-132220
Published: 2019
Journal Articles

Development TACI and Bcma Dual-Antigen Targeted Immunotherapy for Multiple Myeloma

Free
Jooeun Bae, PhD, Teru Hideshima, MD PhD, Mehmet Kemal Samur, PhD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3138.
https://doi.org/10.1182/blood-2019-128689
Published: 2019
Journal Articles

A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)

Free
Elisabet E. Manasanch, MD, Sundar Jagannath, MD, Hans C. Lee, MD, Krina K. Patel, MDMSc, Connor Graham, BA, Gregory P. Kaufman, MD, Sheeba K. Thomas, MD, Swami Iyer, Sham Mailankody, MBBS, Neha Korde, MD, Behrang Amini, MD PhD, Pei Lin, MDDM,MDC, Zuzana Berkova, PhD, Donna M. Weber, MD, Feng Lei, MS, Nikoletta Lendvai, MD PhD, Michelle Hildebrandt, PhD, Sattva S Neelapu, MD, Robert Z. Orlowski, MD, PhD, Ola Landgren, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3116.
https://doi.org/10.1182/blood-2019-123205
Published: 2019
Journal Articles

Impact of Previous Cancer Therapy on Outcome of Patients with Multiple Myeloma or Smoldering Disease

Free
Fahrettin Covut, MD, Gayathri Ravi, MD, James Driscoll, MD PhD, Marcos de Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3174.
https://doi.org/10.1182/blood-2019-126059
Published: 2019
Journal Articles

Single Arm, Prospective, Open-Label Phase II Trial to Evaluate the Efficacy of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance

Free
Vikram Premkumar, MD, Suzanne Lentzsch, MD PhD, Divaya Bhutani, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3161.
https://doi.org/10.1182/blood-2019-123496
Published: 2019
Journal Articles

Qip-Mass Spectrometry in High Risk Smoldering Multiple Myeloma Patients Included in the GEM-CESAR Trial: Comparison with Conventional and Minimal Residual Disease IMWG Response Assessment

Free
Noemi Puig, MD PhD, Maria-Victoria Mateos, Teresa Contreras, Bruno Paiva, PhD, María Teresa Cedena, José J Pérez, Irene Aires, Cristina Agullo, Joaquin Martinez-Lopez, MD PhD, Paula Rodriguez Otero, Veronica Gonzalez De La Calle, MD PhD, Marta Sonia Gonzalez, MD, Albert Oriol, Norma C. Gutierrez, MD PhD, Rafael Rios, MD PhD, Laura Rosiñol, Miguel Angel Alvarez, MD, Maria Jose Calasanz, PhD BSc, Joan Bargay, MD PhD, Ana Pilar Gonzalez, PhD, Adrián Alegre, MD, Fernando Escalante, MD, Rafael Martínez, Javier de la Rubia, MD PhD, Ana Isabel Teruel, MDcal Doctor, Felipe De Arriba, PhD, Luis Palomera, MD PhD, Miguel-Teodoro Hernández, Javier López, MD, Jesús Martín, Aránzazu García Mateo, PhD, Ramón García-Sanz, MD PhD, Enrique M. Ocio, Joan Bladé, MD PhD, Juan-José Lahuerta, MD PhD, Jesus F. San-Miguel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 581.
https://doi.org/10.1182/blood-2019-127717
Published: 2019
Journal Articles

Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Free
Mark Bustoros, MD, Omar Nadeem, MD, Adam S Sperling, MD PhD, Giada Bianchi, MD, Lily Ardente, BS, Robert A. Redd, MS, Julia Prescott, NP, Erin Frey, RN, Kathleen Guimond, RN, Rachel Styles, BS, Kalvis Hornburg, BA, Alexandra Savell, BS, Nang Kham Su, BA, Govind Bindra, BA, Cody J Boehner, BS, Kaitlen Reyes, DNP, Houry Leblebjian, PharmD, Diane Warren, Nikhil C. Munshi, MD, Jacob P. Laubach, MD, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Irene M. Ghobrial, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 580.
https://doi.org/10.1182/blood-2019-128519
Published: 2019
Journal Articles

The Utilization of Screening Tests for Plasma Cell Dyscrasias By Internal Medicine Physicians at a Teaching Hospital

Free
Omar Abughanimeh, MD, Ahmad Al-Shyoukh, Anahat Kaur, MD, Diala Alawneh, Soheila Hamidpour, Anuj Shrestha, MD, Sheshadri Madhusudhana, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4732.
https://doi.org/10.1182/blood-2019-123077
Published: 2019
Journal Articles

Heavy and Light Chain Monitoring in High Risk Smoldering Multiple Myeloma Patients Included in the GEM-CESAR Trial: Comparison with Conventional and Minimal Residual Disease IMWG Response Assessment

Free
Noemi Puig, MD PhD, Teresa Contreras, Bruno Paiva, PhD, María Teresa Cedena, José J Pérez, Irene Aires, Cristina Agullo, Joaquin Martinez-Lopez, MD PhD, Paula Rodriguez Otero, Veronica Gonzalez De La Calle, MD PhD, Marta Sonia Gonzalez, MD, Albert Oriol, Norma C. Gutierrez, MD PhD, Rafael Rios, MD PhD, Laura Rosiñol, Miguel Angel Alvarez, MD, Maria Jose Calasanz, PhD BSc, Joan Bargay, MD PhD, Ana Pilar Gonzalez, PhD, Adrián Alegre, MD, Fernando Escalante, MD, Rafael Martínez, Javier de la Rubia, MD PhD, Ana Isabel Teruel, MDcal Doctor, Felipe De Arriba, PhD, Luis Palomera, MD PhD, Miguel-Teodoro Hernández, Javier López, MD, Jesús Martín, Aránzazu García Mateo, PhD, Enrique M. Ocio, Ramón García-Sanz, MD PhD, Joan Bladé, MD PhD, Juan Jose Lahuerta, MD PhD, Jesus F. San-Miguel, MD, Maria-Victoria Mateos
Journal: Blood
Blood (2019) 134 (Supplement_1): 1852.
https://doi.org/10.1182/blood-2019-128655
Published: 2019
Journal Articles

Using Current Clinical Markers to Define High Risk Smoldering Multiple Myeloma: Agree to Disagree

Free
Elizabeth Hill, MD, Neha Korde, MD, Sham Mailankody, MBBS, Candis Morrison, CNP, PhD, Alexander Dew, DO, Jennifer Hsu Albert, RN, Katherine Graap, RN, Francesco Maura, MD, Ola Landgren, MD PhD, Dickran Kazandjian, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1794.
https://doi.org/10.1182/blood-2019-126952
Published: 2019
Journal Articles

Short-Term Risk of Progression of Patients with Asymptomatic Monoclonal Gammopathies to Active Multiple Myeloma: The Critical Impact of the Tumoral Mass

Free
Anna Benedetta Dalla Palma, MD, Laura Notarfranchi, MD, Jessica Crosara, MD, Mario Pedrazzoni, MD, Fabrizio Accardi, MD, Valentina Marchica, MS, Denise Toscani, PhD, Emanuela Vicario, PhD, Paola Storti, PhD, Nicola Giuliani
Journal: Blood
Blood (2019) 134 (Supplement_1): 1795.
https://doi.org/10.1182/blood-2019-128252
Published: 2019
Journal Articles

Risk of Progression in Patients with Smoldering Myeloma

Free
Fahrettin Covut, MD, Kamal Chamoun, MD, Leland Metheny, III, MD, Kirsten M Boughan, DO, James Driscoll, MD PhD, Marcos de Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1892.
https://doi.org/10.1182/blood-2019-127677
Published: 2019
Journal Articles

Accumulation of Endogenous DNA Damage Sustain Malignant Progression and Increase Therapy Resistance in Multiple Myeloma

Free
Maria Gkotzamanidou, MD PhD, Evangelos Terpos, MD PhD, Nikhil C. Munshi, MD, Vassilis L. Souliotis, PhD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1788.
https://doi.org/10.1182/blood-2019-123502
Published: 2019